News
Africa, Weight loss and Food and Drug Administration
Digest more
Johannesberg: Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its ...
6d
Bizcommunity on MSNDanish weight-loss drug Wegovy debuts in South Africa, challenging Eli Lilly
Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa, marking its debut in Africa and ...
Updated on: May 12, 2025 / 12:39 PM EDT / CBS News ...
Celeste Ntuli opened up on her battle with obesity. The star's comments comes as Mzansi is discussing the new looks of celebs ...
Key Takeaways Wegovy is considered a safe and effective treatment for long-term weight loss. Possible problems with long-term use include pancreatitis, gallbladder disease, and kidney damage.
Wegovy was the first to market from a newer generation of medicines known as GLP-1 agonists, originally developed for diabetes, that provide a new way to address record obesity rates.
U.S. prices for obesity-treatment pills that Eli Lilly and Novo Nordisk aim to launch next year likely will be on par with ...
Wegovy’s starting dosage is a 0.25-milligram (mg) injection once per week. You’ll typically increase your dose every 4 weeks, up to 1.7 mg per week or 2.4 mg per week. Your doctor may adjust ...
While the 10-fold increase in dose over injectable Wegovy has raised questions about the launch, Novo Nordisk has assured ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results